Search Within

Irene Y Cheung

  1. "Shakeel Modak"
Formats
  1. Journal Article (22)
  2. Meeting Abstract (6)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (28)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (28)
  3. GSK Faculty (28)
  4. General Oncology Service (28)
  5. Neuroblastoma Service (28)
  6. Pediatrics, Department of (28)

More Groups

People
  1. Nai-Kong Cheung (28)
  2. Shakeel Modak (28)
  3. Brian Kushner (24)
  4. Kim Kramer (13)
  5. Stephen Roberts (13)
  6. Ellen Basu (12)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (3)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. OncoImmunology (4)
  3. Pediatric Blood and Cancer (4)
  4. Cancer Research (3)
  5. Clinical Cancer Research (3)
  6. Hybridoma and Hybridomics (2)

More Publications

Publishers
  1. American Association for Cancer Research (6)
  2. American Society of Clinical Oncology (4)
  3. Landes Bioscience (4)
  4. Wiley Periodicals, Inc (4)
  5. American Medical Association (2)
  6. Impact Journals (2)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma
    Journal Article

    Modak, S.; Kushner, B. H.; Kramer, K.; Vickers, A.; Cheung, I. Y.; Cheung, N. K. V.
    OncoImmunology (2013)

    Fulltext@MSK | Save
  • Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte- macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission
    Journal Article

    Cheung, N. K. V.; Cheung, I. Y.; Kushner, B. H.; Ostrovnaya, I.; Chamberlain, E.; Kramer, K.; Modak, S.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma
    Journal Article

    Modak, S.; Cheung, I. Y.; Kushner, B. H.; Kramer, K.; Reich, L.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • KIR/HLA genotypes predictive of missing KIR ligands are associated with improved outcome in patients with high-risk neuroblastoma treated with anti-GD2 monoclonal antibody therapy
    Meeting Abstract

    Gallagher, M.; Tarek, N.; Zheng, J. T.; Venstrom, J. M.; Cheung, I. Y.; Modak, S.; Dupont, B.; Cheung, N. K. V.; Hsu, K. C.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • NK cell killer Ig-like receptor (KIR) genotype as a novel biomarker for neuroblastoma patients receiving anti-GD2 monoclonal antibody 3F8
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Kushner, B. H.; Modak, S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: Broad implications for immunotherapy
    Journal Article

    Kushner, B. H.; Cheung, I. Y.; Kramer, K.; Modak, S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2007)

    Fulltext@MSK | Save
  • Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapy
    Journal Article

    Cheung, N. K. V.; Guo, H. F. ; Modak, S.; Cheung, I. Y.
    Hybridoma and Hybridomics (2003)

    Fulltext@MSK | Save
  • Anti-idiotypic antibody as the surrogate antigen for cloning scFv and its fusion proteins
    Journal Article

    Cheung, N. K. V.; Guo, H. F. ; Modak, S.; Cheung, I. Y.
    Hybridoma and Hybridomics (2002)

    Fulltext@MSK | Save